Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy

被引:103
作者
Langendijk, JA
Slotman, BJ
van der Waal, I
Doornaert, P
Berkof, J
Leemans, CR
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Maxillary Surg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands
关键词
head and neck carcinoma; radiotherapy; prognostic factors; overall treatment time;
D O I
10.1002/cncr.21340
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The objective of this study was to define different prognostic groups with regard to locoregional control (LRC) derived from recursive partitioning analysis (RPA). METHODS. Eight hundred one patients with squamous cell head and neck carcinoma underwent with primary surgery and received postoperative radiotherapy. For the definition of prognostic groups, the method of classification and regression trees was performed, including a large number of well known prognostic factors. RESULTS. The final model was composed of six prognostic factors for LRC, resulting in seven terminal nodes. RPA Class I (intermediate risk) consisted of 381 patients who had no N3 lymph nodes, free surgical margins (> 5 mm), and no extranodal spread (ENS). RPA Class 11 (high risk) consisted of 189 patients who had 1 positive lymph node with ENS or had T1, T2, or T4 tumors with close or positive surgical margins. RPA Class III (very high risk) consisted of 231 patients who had a N3 neck, 2 positive lymph nodes with ENS, or a T3 tumor with close or positive surgical margins. The 5-year LRC rate was 88%, 73% and 58%, in RPA Class 1, 11, and III, respectively (P < 0.0001). The hazard ratio (HR) relative to RPA Class I was 2.3 (95% confidence interval [95%CI], 1.5-3.6) for RPA Class II and 4.2 (95%CI, 2.8-6.1) for RPA Class III. CONCLUSIONS. The RPA classification scheme studied allowed for the clear definition of three prognostic groups with regard to LRC and OS. These groups may be useful in the design of future prospective, randomized studies investigating new treatment modalities.
引用
收藏
页码:1408 / 1417
页数:10
相关论文
共 50 条
  • [41] Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma
    Liu, Qing
    Tu, Xue-Hua
    Yu, Rui-Xuan
    Wen, Hong-Ying
    Guo, Xiao-Guang
    Ma, Dai-Yuan
    Jiang, Kai-Yuan
    Tian, Dong
    [J]. CANCER MEDICINE, 2024, 13 (16):
  • [42] Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma
    Krstevska, V.
    [J]. JOURNAL OF BUON, 2009, 14 (03): : 361 - 373
  • [43] Monocyte-to-lymphocyte ratio as a prognostic indicator in head and neck squamous cell carcinoma treated with radiotherapy
    Takano, H.
    Tanaka, H.
    Ono, T.
    Kajima, M.
    Manabe, Y.
    Matsuo, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2023, 21 (04): : 679 - 684
  • [44] Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review
    Bonomo, Pierluigi
    Loi, Mauro
    Desideri, Isacco
    Ohnetto, Emanuela
    Delli Paoli, Camilla
    Terziani, Francesca
    Greto, Daniela
    Mangoni, Monica
    Scoccianti, Silvia
    Simontacchi, Gabriele
    Francolini, Giulio
    Meattini, Icro
    Caini, Saverio
    Livi, Lorenzo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 120 : 98 - 110
  • [45] Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy-A Systematic Review
    Schanne, Daniel H.
    Koch, Alexander
    Elicin, Olgun
    Giger, Roland
    Medova, Michaela
    Zimmer, Yitzhak
    Aebersold, Daniel M.
    [J]. BIOMEDICINES, 2022, 10 (12)
  • [46] Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab
    Nishikawa, Daisuke
    Suzuki, Hidenori
    Beppu, Shintaro
    Terada, Hoshino
    Sawabe, Michi
    Kadowaki, Shigenori
    Sone, Michihiko
    Hanai, Nobuhiro
    [J]. CANCER SCIENCE, 2021, 112 (01) : 339 - 346
  • [47] Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck – clinical results from the cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”
    Cornelius Maihoefer
    Lars Schüttrumpf
    Corinna Macht
    Ulrike Pflugradt
    Julia Hess
    Ludmila Schneider
    Christine Woischke
    Axel Walch
    Philipp Baumeister
    Thomas Kirchner
    Horst Zitzelsberger
    Claus Belka
    Ute Ganswindt
    [J]. Radiation Oncology, 13
  • [48] Risk Factors and Survival Outcomes for Patients With Anastomotic Leakage After Surgery for Head and Neck Squamous Cell Carcinoma
    Kim, Do-Youn
    Roh, Jong-Lyel
    Choi, Jong Woo
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    [J]. CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, 2014, 7 (01) : 36 - 41
  • [49] Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
    Johnson, Jennifer M.
    Vathiotis, Ioannis A.
    Harshyne, Larry A.
    Ali, Ayesha
    Bar Ad, Voichita
    Axelrod, Rita
    Lorber, Emily
    Curry, Joseph
    Cognetti, David M.
    Luginbuhl, Adam J.
    Tuluc, Madalina
    Keith, Scott
    Mahoney, My G.
    Argiris, Athanassios
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [50] Primary rectal squamous cell carcinoma treated with surgery and radiotherapy
    Wang, Jun-Feng
    Wang, Zhen-Xing
    Xu, Xiao-Xiao
    Wang, Cui
    Liu, Jian-Zhong
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (14) : 4106 - 4109